Whilst the full-length KLF6 is established as a tumour suppressor in many cancer types, KLF6-SV1 is deemed to be pro-oncogenic by antagonising the full-length KLF6 functions in a dominant-negative manner. The gene discussed is KLF6; the disease is cancer.